Evidence supporting product standards for carcinogens in smokeless tobacco products.
Evidence supporting product standards for carcinogens in smokeless tobacco products.
复制标题
DOI:
10.1158/1940-6207.capr-14-0250
复制
发表时间:
2015-01
期刊:
影响因子:
--
通讯作者:
Hecht SS
中科院分区:
文献类型:
--
作者:
Hatsukami DK;Stepanov I;Severson H;Jensen JA;Lindgren BR;Horn K;Khariwala SS;Martin J;Carmella SG;Murphy SE;Hecht SS
Smokeless tobacco (ST) products sold in the U.S. vary significantly in yields of nicotine and tobacco-specific nitrosamines (TSNA). With the passage of the Family Smoking Prevention and Tobacco Control Act, the Food and Drug Administration now has the authority to establish product standards. However, limited data exist determining the relative roles of pattern of ST use versus constituent levels in the ST product in exposure of users to carcinogens. In this study, ST users of brands varying in nicotine and TSNA content were recruited from three different regions in the U.S. Participants underwent two assessment sessions. During these sessions, demographic and ST use history information along with urine samples to assess biomarkers of exposure and effect were collected. During the time between data collection, ST users recorded the amount and duration of ST use on a daily basis using their diary cards. Results showed that independent of pattern of ST use and nicotine yields, levels of TSNA in ST products played a significant role in carcinogen exposure levels. Product standards for reducing levels of TSNA in ST products are necessary to decrease exposure to these toxicants and potentially to reduce risk for cancer.